Evidence map›Paper›PMID 39424794›Full record

ArticleNature communications2024

Identifying septic shock subgroups to tailor fluid strategies through multi-omics integration.

Zhongheng Zhang, Lin Chen, Bin Sun, Zhanwei Ruan, Pan Pan, Weimin Zhang, Xuandong Jiang, Shaojiang Zheng, Shaowen Cheng, Lina Xian and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Genetic associations in sepsis and ARDS.Frontiers in pharmacology · 2026
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Observational
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Zhongheng Zhang *Department of Emergency Medicine, Provincial Key Laboratory of Precise Diagnosis and Treatment of Abdominal Infection, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. zh_zhang1984@zju.edu.cn.ORCID 0000-0002-2336-5323
Lin Chen *Department of Neurosurgery, Neurological Intensive Care Unit, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
Bin SunDepartment of Emergency Medicine, Binzhou Medical University Hospital, Binzhou, People's Republic of China.
Zhanwei RuanDepartment of Emergency, Third Affiliated Hospital, Wenzhou Medical University, Wenzhou, China.
Pan PanCollege of Pulmonary & Critical Care Medicine, 8th Medical Center, Chinese PLA General Hospital, Beijing, China.
Weimin ZhangIntensive Care Unit, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, People's Republic of China.
Xuandong JiangIntensive Care Unit, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, People's Republic of China.ORCID 0000-0002-6533-8112
Shaojiang Zheng *Key Laboratory of Emergency and Trauma of Ministry of Education, Engineering Research Center for Hainan Biological Sample Resources of Major Diseases,Key Laboratory of Tropical Cardiovascular Diseases Research of Hainan Province, The First Affiliated Hospital of Hainan Medical University, Hainan, China.ORCID 0000-0002-2323-0736
Shaowen Cheng *Department of Wound Repair, Key Laboratory of Emergency and Trauma of Ministry of Education, The First Affiliated Hospital of Hainan Medical University, Haikou, China.
Lina XianDepartment of Intensive Care Unit, The First Affiliated Hospital of Hainan Medical University, Haikou, China.
Bingshu WangDepartment of Pathology, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.
Jie YangDepartment of Emergency Medicine, Provincial Key Laboratory of Precise Diagnosis and Treatment of Abdominal Infection, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Bo ZhangDepartment of Emergency Medicine, Provincial Key Laboratory of Precise Diagnosis and Treatment of Abdominal Infection, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Ping XuEmergency Department, Zigong Fourth People's Hospital, Zigong, China.
Zhitao ZhongEmergency Department, Zigong Fourth People's Hospital, Zigong, China.
Lingxia ChengEmergency Department, Zigong Fourth People's Hospital, Zigong, China.
Hongying NiDepartment of Critical Care Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.
Chinese Multi-omics Advances In Sepsis (CMAISE) Consortium
Yucai HongDepartment of Emergency Medicine, Provincial Key Laboratory of Precise Diagnosis and Treatment of Abdominal Infection, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82272180
6 · The paper itself

Abstract

Fluid management remains a critical challenge in the treatment of septic shock, with individualized approaches lacking. This study aims to develop a statistical model based on transcriptomics to identify subgroups of septic shock patients with varied responses to fluid strategy. The study encompasses 494 septic shock patients. A benefit score is derived from the transcriptome space, with higher values indicating greater benefits from restrictive fluid strategy. Adherence to the recommended strategy is associated with a hazard ratio of 0.82 (95% confidence interval: 0.64-0.92). When applied to the baseline hospital mortality rate of 16%, adherence to the recommended fluid strategy could potentially lower this rate to 13%. A proteomic signature comprising six proteins is developed to predict the benefit score, yielding an area under the curve of 0.802 (95% confidence interval: 0.752-0.846) in classifying patients who may benefit from a restrictive strategy. In this work, we develop a proteomic signature with potential utility in guiding fluid strategy for septic shock patients.

Indexed as

Fluid TherapyProteomicsShock, SepticAgedFemaleHospital MortalityHumansMaleMiddle AgedMultiomicsTranscriptome

Identifiers

PMID39424794
PMCPMC11489719

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.